Scientific jobs

Scientific jobs

As a scientific officer at EMA, you will typically be responsible for activities related to human or veterinary medicines in areas such as procedure and scientific management, scientific committee support, pharmacovigilance, and inspections and quality.

You will have obtained a degree in a science field and have proven work experience in the field of medicines regulation from the pharmaceutical industry, a national competent authority or academia. You will have knowledge and understanding of scientific aspects of medicines development, clinical trials methodology, signal detection and pharmacoepidemiology. You will be a curious, solution-driven team player who can communicate verbally and in writing with various audiences.

Search results for "". Page 1 of 2, Results 1 to 25 of 32
Title Deadline for application Type of position
Trainees (Process Documentation)
Trainees (Process Documentation) 6 May 2025 23:59 CET Trainee
6 May 2025 23:59 CET Trainee
Trainee (Veterinary Pharmacovigilance)
Trainee (Veterinary Pharmacovigilance) 6 May 2025 23:59 CET Trainee
6 May 2025 23:59 CET Trainee
Trainee (Vaccines Outreach Group / stakeholders listening) 6 May 2025 23:59 CET Trainee
Trainee (Transparency and publication)
Trainee (Transparency and publication) 6 May 2025 23:59 CET Trainee
6 May 2025 23:59 CET Trainee
Trainee (therapies for cardiovascular diseases) 6 May 2025 23:59 CET Trainee
Trainee (Strengthening Quality & Knowledge management of the Agency's scientific committees) 6 May 2025 23:59 CET Trainee
Trainee (SME - Small and Medium sized Enterprises Office) 6 May 2025 23:59 CET Trainee
Trainee (Research on psychostimulants' off-label use in paediatric and young adults patients) 6 May 2025 23:59 CET Trainee
Trainee (Relationship between study population,subgroup analyses & indication for cancer medicines) 6 May 2025 23:59 CET Trainee
Trainee (Regulatory science considerations and conclusions in assessments of new medicines) 6 May 2025 23:59 CET Trainee
Trainee (Optimising feasibility assessment for RWD studies) 6 May 2025 23:59 CET Trainee
Trainee (Optimising assessments in the context of referral procedures) 6 May 2025 23:59 CET Trainee
Trainee (Non-clinical & 3Rs expertise & knowledge & information across EMA and its Network) 6 May 2025 23:59 CET Trainee
Trainee (new initiatives on activities related to strengthening innovation in the EU) 6 May 2025 23:59 CET Trainee
Trainee (metadata analysis and catalogue of validated data sources in the veterinary domain) 6 May 2025 23:59 CET Trainee
Trainee (Labeling and naming policy)
Trainee (Labeling and naming policy) 6 May 2025 23:59 CET Trainee
6 May 2025 23:59 CET Trainee
Trainee (International Collaboration in medicine shortages) 6 May 2025 23:59 CET Trainee
Trainee (Inspections Office)
Trainee (Inspections Office) 6 May 2025 23:59 CET Trainee
6 May 2025 23:59 CET Trainee
Trainee (Implementation and impact analysis of the new Variation Regulation) 6 May 2025 23:59 CET Trainee
Trainee (Focus on sustainability of network operation (BWP/QWP) and risk-based approaches) 6 May 2025 23:59 CET Trainee
Trainee (Enhancing data use and impact assessment to accelerate clinical trials in the EU) 6 May 2025 23:59 CET Trainee
Trainee (EMA's Horizon Scanning)
Trainee (EMA's Horizon Scanning) 6 May 2025 23:59 CET Trainee
6 May 2025 23:59 CET Trainee
Trainee (Database of centrally approved antibiotics and antifungals) 6 May 2025 23:59 CET Trainee
Trainee (Data Governance at the EMA)
Trainee (Data Governance at the EMA) 6 May 2025 23:59 CET Trainee
6 May 2025 23:59 CET Trainee
Trainee (Clinical trials methodology and analytics for regulatory decisions) 6 May 2025 23:59 CET Trainee

What is it like to work in the Human Medicines Division?

Regulatory Science to 2025 - Shaping the future

 

As science and technology advance and bring potential new treatments and diagnostic tools, regulatory science must advance in tandem so that these can be correctly, rigorously and efficiently assessed. Examples of the transformational research that is having a significant impact on the regulatory science agenda include cell-based therapies, genomics-based diagnostics, drug-device combinations, novel clinical trial design, predictive toxicology, real-world evidence, and ‘big data’ and artificial intelligence.